Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
23.99
-0.31 (-1.28%)
Dec 20, 2024, 4:00 PM EST - Market closed
Dyne Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 2,441 | 816 | 604 | 606 | 954 | - | |
| Market Cap Growth | 559.61% | 35.12% | -0.31% | -36.50% | - | - | |
| Enterprise Value | 1,743 | 687 | 387 | 233 | 585 | - | |
| Last Close Price | 23.99 | 13.30 | 11.59 | 11.89 | 21.00 | - | |
| PB Ratio | 3.46 | 8.94 | 2.39 | 1.65 | 2.79 | - | |
| P/TBV Ratio | 5.11 | 8.94 | 2.39 | 1.65 | 2.79 | - | |
| Debt / Equity Ratio | 0.04 | 0.30 | 0.12 | 0.09 | - | - | |
| Quick Ratio | 16.73 | 2.41 | 9.11 | 13.11 | 31.49 | 6.21 | |
| Current Ratio | 17.02 | 2.53 | 9.46 | 13.31 | 31.83 | 6.26 | |
| Return on Equity (ROE) | -68.69% | -137.31% | -54.18% | -42.02% | -33.35% | -163.12% | |
| Return on Assets (ROA) | -40.35% | -64.21% | -29.19% | -24.07% | -19.83% | -69.96% | |
| Return on Capital (ROIC) | -43.16% | -75.38% | -31.26% | -25.23% | -20.57% | -80.04% | |
| Earnings Yield | -12.06% | -28.90% | -27.83% | -24.63% | -6.23% | - | |
| FCF Yield | -10.01% | -23.14% | -25.94% | -20.33% | -4.99% | - | |
| Buyback Yield / Dilution | -45.97% | -14.83% | -2.12% | -253.54% | -489.30% | -415.39% | |
| Total Shareholder Return | -45.97% | -14.83% | -2.12% | -253.54% | -489.30% | -415.39% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.